BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31274185)

  • 21. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
    Ramamoorthy B; Nilubol N
    Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]   [Full Text] [Related]  

  • 25. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
    Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
    Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
    Kövesdi A; Tóth M; Butz H; Szücs N; Sármán B; Pusztai P; Tőke J; Reismann P; Fáklya M; Tóth G; Somogyi A; Borka K; Erdei A; Nagy EV; Deák V; Valkusz Z; Igaz P; Patócs A; Grolmusz VK
    Endocrine; 2019 Aug; 65(2):451-459. PubMed ID: 31044390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
    de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
    Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan.
    Sakurai A; Yamazaki M; Suzuki S; Fukushima T; Imai T; Kikumori T; Okamoto T; Horiuchi K; Uchino S; Kosugi S; Yamada M; Komoto I; Hanazaki K; Itoh M; Kondo T; Mihara M; Imamura M
    Endocr J; 2012; 59(10):859-66. PubMed ID: 22785103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
    Horiuchi K; Okamoto T; Iihara M; Tsukada T
    Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
    Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1.
    Raghavan R; Shah S; Kondkar AA; Dherai AJ; Desai D; Chauhan P; Lala M; Ashavaid TF
    Mol Diagn Ther; 2007; 11(2):129-31. PubMed ID: 17397250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1 (MEN1).
    Carroll RW
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):297-309. PubMed ID: 23279763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).
    Hai N; Aoki N; Matsuda A; Mori T; Kosugi S
    Eur J Endocrinol; 1999 Nov; 141(5):475-80. PubMed ID: 10576763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile.
    Damianse SSP; Nascimento GC; Rocha VCC; Nascimento AGPAC; Gaido NC; Azulay RSS; Dos Santos WC; Rodrigues VP; Quidute ARP; Magalhães M; Dos S Faria M
    Endocr Pract; 2022 May; 28(5):509-514. PubMed ID: 35247589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
    Simonds WF
    Front Endocrinol (Lausanne); 2023; 14():1183297. PubMed ID: 37409236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
    Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical aspects of multiple endocrine neoplasia type 1.
    Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
    Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.